# Predictive Value of Human Microbiome and Serological Markers for Clinical Outcome of AIS With Active Cancer

> **NCT05553990** · — · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 200 (estimated)

## Conditions studied

- Ischemic Stroke, Acute
- Tumor Progression

## Interventions

- **OTHER:** intestinal flora disturbance

## Key facts

- **NCT ID:** NCT05553990
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-07
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05553990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05553990, "Predictive Value of Human Microbiome and Serological Markers for Clinical Outcome of AIS With Active Cancer". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT05553990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*